Tag: Turning Point Therapeutics, Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Turning Point Therapeutics, Inc.

Turning Point Therapeutics Names Carol Gallagher, Pharm.D. to its Board of Directors

Added to Collection on: 2019-07-24 20:22:30

Tags for this article:

Biotechnology
Forward-looking statement
Gilead Sciences
Life Sciences
Turning Point Therapeutics, Inc.
Carol Gallagher

Click the tags to see associated articles and topics

View Article Details
Should You Expect A Quick Recovery From Turning Point Therapeutics, Inc. (NASDAQ:TPTX) After ...

Added to Collection on: 2020-12-12 18:56:15

Tags for this article:

Financial markets
Finance
Stock market
Financial economics
Stock
Initial public offering
Day trading
Short
NASDAQ
Turning Point Therapeutics, Inc.

Click the tags to see associated articles and topics

View Article Details
Buy, Sell Or Hold Turning Point Therapeutics, Inc. (NASDAQ:TPTX) At $124.54?

Added to Collection on: 2020-12-19 18:56:15

Tags for this article:

Financial markets
Stock market
Finance
Financial economics
Equity securities
Financial regulation
Corporate finance
Stock
Short
NASDAQ
Initial public offering
Share
Turning Point Therapeutics, Inc.

Click the tags to see associated articles and topics

View Article Details
Matthews International Capital Management Llc Buys Sea, JD.com Inc, XPeng Inc, Sells Alibaba ...

Added to Collection on: 2021-02-09 16:41:15

Tags for this article:

Companies
Financial markets
Finance
JD.com
Stock
NASDAQ-100
Navistar International
BlackRock
Matthews International Capital Management Llc
jd.com inc
Alibaba Group Holding
Tencent Music Entertainment Group
KE Holdings Inc
XPeng Inc.
Yatsen Holding Ltd.
JOYY Inc.
Turning Point Therapeutics, Inc.

Click the tags to see associated articles and topics

View Article Details
International Biotechnology Trust Plc Buys ChemoCentryx Inc, Turning Point Therapeutics Inc ...

Added to Collection on: 2021-02-19 23:37:30

Tags for this article:

Life Sciences
Biotechnology
Pharmaceutical industry
Specialty drugs
AstraZeneca
Gilead Sciences
Alexion Pharmaceuticals
Vertex Pharmaceuticals
Stock
NASDAQ-100
Amgen Inc.
Neurocrine Biosciences Inc.
Mirati Therapeutics Inc.
ChemoCentryx Inc
Vertex Pharmaceuticals Inc
Myokardia Inc
Biogen Inc.
Turning Point Therapeutics, Inc.
Iovance Biotherapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
-$0.54 Earnings Per Share Expected for Turning Point Therapeutics, Inc. (NASDAQ:TPTX) This ...

Added to Collection on: 2021-03-08 13:30:00

Tags for this article:

Finance
Stock market
Equity securities
Financial economics
Corporate finance
Stock
Price?earnings ratio
Share
Lord Abbett
Turning Point Therapeutics, Inc.

Click the tags to see associated articles and topics

View Article Details
Should be in your portfolio for great total return: Turning Point Therapeutics Inc. (TPTX), Bioceres ...

Added to Collection on: 2021-03-20 14:48:01

Tags for this article:

Financial markets
Stock market
Corporate finance
Finance
Financial economics
Equity securities
Stock
Technical analysis
Mergers and acquisitions
Turning Point Therapeutics, Inc.
T . ROWE PRICE ASSOCIATES , INC

Click the tags to see associated articles and topics

View Article Details
Turning Point Therapeutics, Inc. (NASDAQ:TPTX) Stops To Thrive In 2021, As Its Stock Is Down ...

Added to Collection on: 2021-03-20 12:00:00

Tags for this article:

Financial markets
Finance
Stock market
Financial economics
Share trading
Corporate finance
Stock
NASDAQ
Short
Day trading
Initial public offering
Penny stock
Turning Point Therapeutics, Inc.

Click the tags to see associated articles and topics

View Article Details
Turning Point Therapeutics, Inc. (NASDAQ:TPTX) Given Consensus Rating of "Buy" by Analysts

Added to Collection on: 2021-05-07 11:37:30

Tags for this article:

Finance
Money
Financial economics
Financial ratios
Financial markets
Equity securities
Stock market
Corporate finance
Dividend
Short
Stock
Share
Turning Point Therapeutics, Inc.

Click the tags to see associated articles and topics

View Article Details
Turning Point Therapeutics Presents Early Clinical Data for Repotrectinib From Care Study ...

Added to Collection on: 2021-10-23 13:44:14

Tags for this article:

Tyrosine kinase receptors
Organ systems
Cancer
Branches of biology
ROS1
ALK inhibitor
Anaplastic lymphoma kinase
Inflammatory myofibroblastic tumour
Neuroblastoma
Radiation therapy
Entrectinib
Crizotinib
Turning Point Therapeutics, Inc.

Click the tags to see associated articles and topics

View Article Details